Defining Value: The Need for a Longer, Broader View

Tomas Philipson, Sachin Kamal-Bahl () and Anupam B. Jena ()
Additional contact information
Sachin Kamal-Bahl: Pfizer Inc.
Anupam B. Jena: Harvard Medical School

PharmacoEconomics, 2017, vol. 35, issue 7, No 1, 669-672

Keywords: Zidovudine; Spillover Effect; Health Technology Assessment; Caregiver Burden; Broad View (search for similar items in EconPapers)
Date: 2017
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40273-017-0503-7 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0503-7

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40273

DOI: 10.1007/s40273-017-0503-7

Access Statistics for this article

PharmacoEconomics is currently edited by Timothy Wrightson and Christopher I. Carswell

More articles in PharmacoEconomics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().